Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$2.49M+87.3%-$7.51M+43.0%-$16.5M-2.4%-$17.01M-9.9%-$19.59M+1.5%
$1.62M-9.4%$1.63M-4.4%$1.72M+9.5%$1.81M+18.9%$1.78M+19.8%
$1.69M+15.6%$1.32M+2.2%$1.02M-57.1%$752K-77.8%$1.46M-64.3%
-$2.22M+55.6%-$12.63M-$10.2M+34.9%-$4.99M+68.6%
$1.04M+218%$1.06M-39.6%$604K$1.21M-33.8%$328K-46.2%
-$1.04M-416%-$1.06M-$604K-106%-$1.21M-107%-$202K-101%
$0-100%$20M
-$28K+99.4%$3.73M+2,377%$10.6M+4,462%$1.96M+191%-$4.74M-405%
-$3.29M+66.9%-$2.63M-124%-$9.45M-2,660%-$9.93M-487%
-$3.26M+38.7%$0-$13.23M-$11.41M+34.7%-$5.32M+67.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does The Oncology Institute, Inc. generate?
The Oncology Institute, Inc. (TOI) generated -$30.0M in operating cash flow over the trailing twelve months.
What is The Oncology Institute, Inc.'s free cash flow?
After $3.9M of capital expenditures, The Oncology Institute, Inc.'s free cash flow was -$27.9M over the trailing twelve months, up 36.7% year over year.
Where does The Oncology Institute, Inc.'s cash flow data come from?
Every line is extracted from The Oncology Institute, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.